Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 48, 2018 - Issue 18
254
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

New potential antitumor quinazolinones derived from dynamic 2-undecyl benzoxazinone: Synthesis and cytotoxic evaluation

&
Pages 2391-2402 | Received 19 May 2018, Published online: 08 Oct 2018

References

  • Alteri, R.; Barzi, A.; Bertaut, T.; Brooks, D.; Chambers, W.; Chang, E. Cancer facts and figure 2017. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html.
  • Harris, C. C.; Hollstein, M. Clinical Implications of the p53 Tumor-Suppressor Gene. N. Engl. J. Med. 1993, 329, 1318–1327. DOI:10.1056/NEJM199310283291807.
  • Shagufta, A. I. Recent Insight into the Biological Activities of Synthetic Xanthone Derivatives. Eur. J. Med. Chem. 2016, 116, 267–280. DOI:10.1016/j.ejmech.2016.03.058.
  • Shagufta, A. I. Recent Developments in Steroidal and Nonsteroidal Aromatase Inhibitors for the Chemoprevention of Estrogen-Dependent Breast Cancer. Eur. J. Med. Chem. 2015, 102, 375–386. DOI:10.1016/j.ejmech.2015.08.010.
  • Shagufta, A. I. Sulfones: An Important Class of Organic Compounds with Diverse biological Activities. Int. J. Pharm. Sci. 2015, 7, 19–27.
  • Demeunynck, M.; Baussanne, I. Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles. CMC. 2013, 20, 794–814 DOI:10.2174/0929867311320060006.
  • Raghavendra, N. M.; Thampi, P.; Gurubasavarajaswamy, P. M.; Sriram, D. Synthesis and Antimicrobial Activities of Some Novel Substituted *2-Imidazolyl-N-(4-Oxo-Quinazolin-3(4H)-yl)-Acetamides. Chem. Pharm. Bull. 2007, 55, 1615–1619. DOI:10.1248/cpb.55.1615.
  • Panneerselvam, P.; Rather, B. A.; Reddy, D. R. S.; Kumar, N. R. Synthesis and anti-Microbial Screening of Some Schiff Bases of 3-Amino-6,8-Dibromo-2-Phenylquinazolin-4(3H)-Ones. Eur. J. Med. Chem. 2009, 44, 2328–2333. DOI:10.1016/j.ejmech.2008.04.010.
  • Verhaeghe, P.; Azas, N.; Gasquet, M.; Hutter, S.; Ducros, C.; Laget, M.; Rault, S.; Rathelot, P.; Vanelle, P. Synthesis and Antiplasmodial Activity of New 4-Aryl-2- Trichloromethylquinazolines. Bioorg. Med. Chem. Lett. 2008, 18, 396–401. DOI:10.1016/j.bmcl.2007.10.027.
  • Saravanan, G.; Pannerselvam, P.; Prakash, C. R. Synthesis, Analgesic and anti-Inflammatory Screening of Novel Schiff Bases of 3-Amino-2-Methylquinazolin-4(3H)-One. J. Adv. Pharm. Tech. Res. 2010, 1, 320–326. DOI:10.4103/0110-5558.72426.
  • Alagarsamy, V.; Solomon, V. R.; Sheorey, R. V.; Jayakumar, R. *3. (3-(3-Ethylphenyl)-2-Substituted Hydrazino-3H-Quinazolin-4-One Derivatives: New Class of Analgesic and Anti-Inflammatory Agents. Chem. Biol. Drug Des. 2009, 73, 471–479. DOI:10.1111/j.1747-0285.2009.00794.x.
  • Smits, R. A.; Adami, M.; Istyastono, E. P.; Zuiderveld, O. P.; van Dam, C. M. E.; de Kanter, F. J. J.; Jongejan, A.; Coruzzi, G.; Leurs, R.; de Esch, I. J. Synthesis and QSAR of Quinazoline Sulfonamides as Highly Potent Human Histamine H4 Receptor Inverse Agonists. J. Med. Chem. 2010, 53, 2390–2400. DOI:10.1021/jm901379s.
  • Georgey, H.; Abdel-Gawad, N.; Abbas, S. Synthesis and Anticonvulsant Activity of Some Quinazolin-4-(3H)-One Derivatives. Molecules. 2008, 13, 2557–2569. DOI:10.3390/molecules13102557.
  • Patel, N. B. Synthesis and Microbial Studies of (4-Oxothiazolidinyl) Sulfonamides Bearing Quinazolin-4(3H)-Ones. Acta Pol. Pharm. 2010, 67, 267–275.
  • Ismail, M. A. H.; Barker, S.; Abou el-Ella, D. A.; Abouzid, K. A. M.; Toubar, R. A.; Todd, M. H. Design and Synthesis of New Tetrazolyl- and Carboxy-Biphenylylmethyl-Quinazolin-4-One Derivatives as Angiotensin II AT1 Receptor Antagonists. J. Med. Chem. 2006, 49, 1526–1535. DOI:10.1021/jm050232e.
  • Zaranappa, V. H. M.; Lokesh, M. R.; Gowdarshivannanava, B. C. Synthesis and Antioxidant Activity of 3-Substituted Schiff Bases of Quinazoline-2,4-Diones. Int. J. Chem. Tech. Res. 2012, 4, 1527–1533.
  • Krishnan, S. K.; Ganguly, S.; Veerasamy, R.; Jan, B. Synthesis, Antiviral and Cytotoxic Investigation of 2-Phenyl-3-Substituted Quinazolin-4(3H)-Ones. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 673–681.
  • Pati, B.; Banerjee, S. Quinazolines: An Illustrated Review. J. Adv. Pharm. Educ. Res. 2013, 3, 136–151.
  • Katrin, S. N. Chemotherapy and Dietary Phytochemical Agents. Chemother. Res. Pract. 2012, 2012, 1–27. DOI:10.1155/2012/282570.
  • Manasa, A. K.; Sidhaye, R. V.; Radhika, G.; Nalini, C. N. Synthesis, Antioxidant and Anticancer Activity of Quinazoline Derivatives. Curr. Pharm. Res. 2011, 1, 101–105.
  • Nerkar, A. G.; Saxena, A. K.; Ghone, S. A.; Thaker, A. K. In Silico Screening, Synthesis and in Vitro Evaluation of Some Quinazolinone and Pyridine Derivatives as Dihydrofolate Reductase Inhibitors for Anticancer Activity. Eur. J. Chem. 2009, 6, S97–S102 DOI:10.1155/2009/506576.
  • Ahmed, M. F.; Youns, M. Synthesis and Biological Evaluation of a Novel Series of 6, 8-Dibromo-4(3H)-Quinazolinone Derivatives as Anticancer Agents. Arch. Pharm. 2013, 44, 617. DOI:10.1002/ardp.201300158.
  • Font, M.; Gonzalez, A.; Palop, J. A.; Sanmartin, C. New Insights into the Structural Requirements for Proapoptotic Agents Based on 2,4-Diaminoquinazoline, 2,4-Diaminopyrido[2,3-d]Pyrimidine and 2,4-Diaminopyrimidine Derivatives. Eur. J. Med. Chem. 2011, 46, 3887–3899. DOI:10.1016/j.ejmech.2011.05.060.
  • Liu, F.; Lovejoy, D. B.; Hassani, A. A.; He, Y.; Herold, J. M.; Chen, X.; Yates, C. M.; Frye, S. V.; Brown, P. J.; Huang, J.; et al. Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-Quinazolines. J. Med. Chem. 2011, 54, 6139–6150. DOI:10.1021/jm200903z.
  • El-Azab, A. S.; Kamal, E. H. Design and Synthesis of Novel 7-Aminoquinazoline Derivatives: Antitumor and Anticonvulsant Activities. Bioorg. Med. Chem. Lett. 2012, 22, 1879–1885. DOI:10.1016/j.bmcl.2012.01.071.
  • Al-Suwaidan, I. A.; Alanazi, A. M.; Abdel-Aziz, A. A.; Mohamed, M. A.; El-Azab, A. S. Design, Synthesis and Biological Evaluation of 2-Mercapto-3-Phenethylquinazoline Bearing Anilide Fragments as Potential Antitumor Agents: Molecular Docking Study. Bioorg. Med. Chem. Lett. 2013, 23, 3935–3941. DOI:10.1016/j.bmcl.2013.04.056.
  • Ismail, R. S. M.; Ismail, N. S. M.; Abuserii, S.; Abou El Ella, D. A. Recent Advances in 4-Aminoquinazoline Based Scaffold Derivatives Targeting EGFR Kinases as Anticancer Agents. Future J. Pharm. Sci. 2016, 2, 9–19. DOI:10.1016/j.fjps.2016.02.001.
  • Madkour, H. M. F.; Azab, M. E.; Mhanna, D. A.; El-Hashash, M. A. Behaviour of Dynamic 6,8- Dibromo-2-Methyl-4-(H)-3,1-Benzoxazin-4-One Towards Some Nitrogen Nucleophiles: Synthesis of New Quinazolinones with Anticipated Biological Activity. Org. Chem. Indian J. 2008, 4, 142–149.
  • Fahmy, A. F. M.; El-Hashash, M. A.; Habashy, M. M.; El-Wannise, S. A. Some Reactions of 2- Isopropyl(4H)-3,1-Benzoxazin-4-One. Rev. Roum. Chim. 1978, 23, 1567–1573.
  • El-Hashash, M. A.; El-Badry, Y. A. Synthesis of a Novel Series of 2,3-Disubstituted Quinazolin- 4(3H)-Ones as a Product of a Nucleophilic Attack at C(2) of the Corresponding 4H-3,1- Benzoxazin-4-One. HCA. 2011, 94, 389–396. DOI:10.1002/hlca.201000230.
  • El-Hashash, M. A.; Shiba, S. A.; El-Bassiouny, F. A.; El-Deen, I. M. Ring-Opening Behavior of 1-(3,4-Dimethyl)Phenyl-5,6,7,8-Tetrachloro-(4h)-3,2-Benzoxazin-4-One. J. Pak. Chem. Soc. 1991, 13, 274–276.
  • Amine, M. S.; El-Hashash, M. A.; Attia, I. A. Synthesis and Reactions of 2-Ethoxycarbonyl-4(3H)-Quinazolinone with Nitrogen Nucleophiles. Indian J. Chem. 2010, 24, 580.
  • Mahmoud, M. R.; El-Shahawi, M. M.; Abu El-Azm, F. S. M. Synthesis of Novel Quinazolinone and Fused Quinazolinones. Eur. J. Chem. 2011, 2, 404–409. DOI:10.5155/eurjchem.2.3.404-409.267.
  • Hekal, M. H.; Abu El-Azm, F. S. M. Efficient MW-Assisted Synthesis of Some New Isoquinolinone Derivatives with In Vitro Antitumor Activity. J. Heterocycl. Chem. 2017, 54, 3056–3064. DOI:10.1002/jhet.2916.
  • Ismail, M. F.; El-Khamry, A. M. A.; Abdel Hamid, A. H.; Emara, S. A. Behaviour of 2-substituted 6,8-Dibromo-3,1-Benzoxazin-4-Ones Towards o-Phenylenediamine and Anthranilic Acid; a Case of Unusual Cleavage of 6,8-d1bromo-2-Methyl-3,1-Benzoxazin-4-One. Tetrahedron. 1988, 44, 3757–3760. DOI:10.1016/S0040-4020(01)86005-1.
  • Ried, W.; Peters, B. Über Triazolylbenzoesäuren Und Acylaminochinazolone Aus Benzoxazinonen Und Carbonsäurehydraziden. Justus Liebigs Ann. Chem. 1969, 729, 124–138. DOI:10.1002/jlac.19697290116.
  • Bischoff, G.; Hoffmann, S. DNA-Binding of Drugs Used in Medicinal Therapies. CMC. 2002, 9, 321–348. DOI:10.2174/0929867023371085.
  • Martinez, R.; Chacon-Garcia, L. The Search of DNA-Intercalators as Antitumoral Drugs: What It Worked and What Did Not Work. CMC. 2005, 12, 127–151. DOI:10.2174/0929867053363414.
  • Kingston, D. G. Tubulin-Interactive Natural Products as Anticancer Agents. J. Nat. Prod. 2009, 72, 507–515. DOI:10.1021/np800568j.
  • Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods. 1983, 65, 55–63. DOI:10.1016/0022-1759(83)90303-4.
  • Denizot, F.; Lang, R. Rapid Colorimetric Assay for Cell Growth and Survival: Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability. J. Immunol. Methods. 1986, 89, 271–277. DOI:10.1016/0022-1759(86)90368-6.
  • Mauceri, H. J.; Hanna, N. N.; Beckett, M. A.; Gorski, D. H.; Staba, M. J.; Stellato, K. A.; Bigelow, K.; Heimann, R.; Gately, S.; Dhanabal, M.; et al. Combined Effects of Angiostatin and Ionizing Radiation in Antitumour Therapy. Nature. 1998, 394, 287–291. DOI:10.1038/28412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.